Brea, CA, United States of America

Mark D Sandison

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beckman Coulter, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark D Sandison. Retrieved from https://idiyas.com/inventor/mark-d-sandison-0kbu2tii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark D. Sandison: Innovator in Chemiluminescent Substrates

Introduction

Mark D. Sandison is a notable inventor based in Brea, California. He has made significant contributions to the field of immunoassays through his innovative work on chemiluminescent substrates. His expertise and dedication have led to advancements that enhance the efficiency and reliability of diagnostic tests.

Latest Patents

Mark D. Sandison holds 1 patent for his invention related to chemiluminescent substrates. His patent focuses on alkaline phosphatase chemiluminescent substrate formulations that exhibit rapid incubation periods and improved stability for use in immunoassays. This innovation is crucial for enhancing the performance of various diagnostic applications.

Career Highlights

Mark is currently employed at Beckman Coulter, Inc., a leading company in the field of diagnostics and laboratory instruments. His role at the company allows him to apply his innovative ideas and contribute to the development of cutting-edge technologies in the healthcare sector.

Collaborations

Throughout his career, Mark has collaborated with talented professionals, including Renuka De Silva and Robert A. Eickholt. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Mark D. Sandison's contributions to the field of chemiluminescent substrates demonstrate his commitment to advancing diagnostic technologies. His work not only enhances the efficiency of immunoassays but also reflects the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…